1. Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. (29th January 2018) Authors: Knox, J J; Barrios, C H; Kim, T M; Cosgriff, T; Srimuninnimit, V; Pittman, K; Sabbatini, R; Rha, S Y; Flaig, T W; Page, R D; Beck, J T; Cheung, F; Yadav, S; Patel, P; Geoffrois, L; Niolat, J; Berkowitz, N; Marker, M; Chen, D; Motzer, R J Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗